2021 Conference on Retroviruses and Opportunistic Infections (CROI) **ADMIN ONLY**
You must Login or Create Account in order to register for this event
March 6-10, 2021
Overview
Who Should Attend
Attendee Criteria
Attendance is prioritized for active researchers and authors of accepted abstracts. Authors of accepted abstracts are preapproved for registration. All other researchers and academics must complete the application process. Applicants should include up to 3 recent relevant key publications in scientific journals (published within the last 3 years) on which they are a MASTHEAD author up to 3 relevant accepted abstracts at scientific or research conferences on which the applicant is an author if available, or other specific details about how they meet the criteria for attending CROI, such as role in teaching or training or patient care.
Examples of eligible attendees, other than authors on accepted abstracts, include:
- Researchers actively participating in basic science investigations, clinical studies, or epidemiologic research of HIV and associated complications and coinfections
- Physicians and scientists who have full-time faculty appointments at academic institutions, including medical school fellowship programs, or practitioners who are involved in patient care or counseling.
- Practitioners who are actively involved in patient care or counseling.
- Individuals who are in training for the above roles.
A limited number of spots are also made available for individuals in leadership positions (1 per organization or in a select few instances in a large organization, up to 2) in major HIV-related organizations (governmental or nongovernmental not-for-profit) that focus on educating healthcare practitioners and other professionals. This includes individuals who are responsible for essential decisions on research and/or research direction.
2021 CROI Description
Since HIV was identified, the scientific response to the global pandemic has been a coordinated effort among basic researchers, clinical investigators, health care providers, epidemiologists, and community leaders to move information and potential treatment options from research to clinical trials and out to affected communities as quickly as possible. CROI was founded in 1993, by researchers working in the field of HIV/AIDS and its complications, as a science-focused forum for exchanging current research findings among their international peers. CROI continues to focus on scientific exchange, providing an environment in which basic science researchers, translational researchers, clinical investigators, epidemiologists, and public health experts meet to present and discuss the latest research into different facets of HIV and its complications, as well as selected other emerging infections.
Learning Objectives
The educational objectives for the 2021 CROI are designed and developed based on the identified needs and knowledge gaps of the attendees.
On completion of the 2021 CROI, participants will be able to:
- Describe basic science research advances in HIV and SARS-CoV-2
- List the most recent findings from clinical trials in the fields of HIV and SARS-CoV-2, as well as the implications of these data for state-of-the-art treatment strategies
- Describe current epidemiologic data on the prevalence of HIV infection, transmission, treatment, and linkage to and retention in care in populations worldwide; the implications of these data for public-health program; planning and current advances in biobehavioral prevention
- Describe current epidemiologic data on the prevalence of SARS-CoV-2 infection, transmission, and treatment
Continuing Education Credits
CME Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this blended activity for a maximum of 46.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 46.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Grant Support
The Conference on Retroviruses and Opportunistic Infections (CROI) is largely supported by the registration fees of participants. In addition, in the interest of objective, balanced, and scientifically rigorous activities, the IAS–USA seeks grant support from commercial companies, particularly from companies with competing products. These companies have no input in or control over the selection of faculty or content of the presentations.
The 2021 Conference on Retroviruses and Opportunistic Infections has, to date, received grant support commitments from the following commercial companies:
Platinum Level Support
Janssen Therapeutics
Gilead Sciences
ViiV Healthcare
Bronze Level Support
Theratechnologies
Hologic
Additional support has been provided by:
Cepheid